Predictive Biomarkers for Immune-Checkpoint Inhibitor Treatment Response in Patients with Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) has one of the highest mortality rates among solid cancers. Late diagnosis and a lack of efficacious treatment options contribute to the dismal prognosis of HCC. Immune checkpoint inhibitor (ICI)-based immunotherapy has presented a new milestone in the treatment of can...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Jun Ho, Ha, Sang Yun, Lee, Danbi, Sankar, Kamya, Koltsova, Ekaterina K., Abou-Alfa, Ghassan K., Yang, Ju Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144688/
https://www.ncbi.nlm.nih.gov/pubmed/37108802
http://dx.doi.org/10.3390/ijms24087640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144688/
https://www.ncbi.nlm.nih.gov/pubmed/37108802
http://dx.doi.org/10.3390/ijms24087640

Ejemplares similares